Skip to main content

Peer Review reports

From: Potent dual MAGL/FAAH inhibitor AKU-005 engages endocannabinoids to diminish meningeal nociception implicated in migraine pain

Original Submission
31 Jan 2023 Submitted Original manuscript
14 Feb 2023 Reviewed Reviewer Report
24 Feb 2023 Reviewed Reviewer Report
24 Feb 2023 Reviewed Reviewer Report
16 Mar 2023 Author responded Author comments - Rashid Giniatullin
Resubmission - Version 2
16 Mar 2023 Submitted Manuscript version 2
Publishing
17 Mar 2023 Editorially accepted
11 Apr 2023 Article published 10.1186/s10194-023-01568-3

You can find further information about peer review here.

Back to article page